CIA
CVS icon

Choate Investment Advisors’s CVS Health CVS Stock Holding History

Choate Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$623K Sell
8,676
-992
-10% -$76.4K 0.01% 283
2025
Q4 		$767K Sell
9,668
-1,161
-11% -$91.5K 0.02% 258
2025
Q3 		$816K Sell
10,829
-6,196
-36% -$425K 0.02% 229
2025
Q2 		$1.17M Buy
17,025
+1,402
+9% +$91.9K 0.03% 183
2025
Q1 		$1.06M Buy
15,623
+901
+6% +$53.9K 0.03% 180
2024
Q4 		$661K Sell
14,722
-5,269
-26% -$296K 0.02% 237
2024
Q3 		$1.26M Sell
19,991
-930
-4% -$54.3K 0.03% 170
2024
Q2 		$1.24M Sell
20,921
-14,082
-40% -$881K 0.03% 171
2024
Q1 		$2.79M Sell
35,003
-14,533
-29% -$1.11M 0.08% 121
2023
Q4 		$3.91M Buy
49,536
+11,601
+31% +$826K 0.12% 91
2023
Q3 		$2.65M Buy
37,935
+6,554
+21% +$464K 0.1% 90
2023
Q2 		$2.17M Sell
31,381
-6,089
-16% -$433K 0.09% 87
2023
Q1 		$2.78M Buy
37,470
+4,386
+13% +$368K 0.13% 68
2022
Q4 		$3.08M Sell
33,084
-4,149
-11% -$400K 0.19% 57
2022
Q3 		$3.55M Buy
37,233
+3,748
+11% +$371K 0.23% 44
2022
Q2 		$3.1M Buy
33,485
+3,439
+11% +$336K 0.19% 53
2022
Q1 		$3.04M Buy
30,046
+3,301
+12% +$347K 0.16% 60
2021
Q4 		$2.76M Buy
26,745
+12,458
+87% +$1.15M 0.16% 64
2021
Q3 		$1.21M Sell
14,287
-645
-4% -$54K 0.08% 109
2021
Q2 		$1.25M Sell
14,932
-1,767
-11% -$145K 0.08% 109
2021
Q1 		$1.26M Buy
16,699
+185
+1% +$13.5K 0.08% 102
2020
Q4 		$1.13M Buy
16,514
+150
+0.9% +$9.76K 0.07% 97
2020
Q3 		$955K Hold
16,364
– – 0.06% 100
2020
Q2 		$1.06M Sell
16,364
-414
-2% -$26.1K 0.08% 91
2020
Q1 		$995K Sell
16,778
-290
-2% -$19.4K 0.08% 100
2019
Q4 		$1.27M Sell
17,068
-1,797
-10% -$126K 0.08% 101
2019
Q3 		$1.19M Sell
18,865
-122
-0.6% -$7.23K 0.07% 101
2019
Q2 		$1.03M Sell
18,987
-115
-0.6% -$6.19K 0.06% 115
2019
Q1 		$1.03M Buy
19,102
+1,319
+7% +$81.4K 0.06% 113
2018
Q4 		$1.17M Sell
17,783
-1,492
-8% -$111K 0.08% 90
2018
Q3 		$1.52M Buy
19,275
+881
+5% +$63K 0.08% 76
2018
Q2 		$1.18M Sell
18,394
-2,059
-10% -$136K 0.07% 100
2018
Q1 		$1.27M Sell
20,453
-12,507
-38% -$897K 0.07% 103
2017
Q4 		$2.39M Buy
32,960
+744
+2% +$54.1K 0.12% 77
2017
Q3 		$2.62M Sell
32,216
-84
-0.3% -$6.64K 0.14% 72
2017
Q2 		$2.6M Sell
32,300
-3,252
-9% -$257K 0.15% 70
2017
Q1 		$2.79M Hold
35,552
– – 0.16% 68
2016
Q4 		$2.81M Buy
35,552
+1,523
+4% +$123K 0.18% 62
2016
Q3 		$3.03M Buy
34,029
+2,504
+8% +$236K 0.2% 56
2016
Q2 		$3.02M Sell
31,525
-3,380
-10% -$337K 0.21% 55
2016
Q1 		$3.62M Buy
34,905
+6,537
+23% +$636K 0.25% 49
2015
Q4 		$2.73M Buy
28,368
+10,243
+57% +$1M 0.2% 70
2015
Q3 		$1.75M Buy
18,125
+262
+1% +$27.5K 0.12% 76
2015
Q2 		$1.87M Sell
17,863
-1,180
-6% -$121K 0.11% 79
2015
Q1 		$1.97M Sell
19,043
-9,325
-33% -$944K 0.11% 78
2014
Q4 		$2.73M Sell
28,368
-536
-2% -$47.2K 0.16% 72
2014
Q3 		$2.3M Sell
28,904
-665
-2% -$52.4K 0.14% 71
2014
Q2 		$2.23M Sell
29,569
-870
-3% -$65.8K 0.13% 77
2014
Q1 		$2.28M Buy
30,439
+744
+3% +$52.6K 0.14% 77
2013
Q4 		$2.13M Sell
29,695
-2,001
-6% -$129K 0.14% 88
2013
Q3 		$1.8M Buy
31,696
+1,045
+3% +$62.3K 0.13% 90
2013
Q2 		$1.75M Buy
+30,651
New +$1.78M 0.14% 89

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Choate Investment Advisors's CVS Position: Q1 2026 in Review

Choate Investment Advisors reduced its CVS Health (CVS) stake by 10% in Q1 2026, selling an estimated $76.4K and leaving 8,676 shares worth $623K. The position accounts for 0.01% of the portfolio, ranked #283.

Choate Investment Advisors first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.91M in Q4 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Choate Investment Advisors held 8,676 shares of CVS Health worth $623K as of Q1 2026.
  • Choate Investment Advisors sold 992 CVS Health shares in Q1 2026, an estimated $76.4K.
  • CVS Health made up 0.01% of Choate Investment Advisors's portfolio in Q1 2026, its #283 holding.
  • Choate Investment Advisors first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Choate Investment Advisors's CVS Health position peaked at $3.91M in Q4 2023.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Choate Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.